Camus 1975.
Methods | RCT, DB, parallel groups Duration 10 days |
|
Participants | Musculoskeletal pain (eg tendon, muscle, or ligament injury) Patients had moderate or mild pain N = 20 M = 8, F = 12 Age range 19 ‐ 86 years |
|
Interventions | Diethylamine salicylate (10%), myrtecaine (1%) cream (Algesal Suractive), n = 10 Placebo cream, n = 10 x 3 daily at the site of pain |
|
Outcomes | PI at rest: 4‐point scale Functional limitation: 5‐point scale Presence of spontaneous pain, swelling, heat Composite score based on above (20 points) Improvement in: PI at rest, Composite score |
|
Notes | Oxford Quality Score: R1, DB2, W0. Total = 3/5 Myrtecaine (Nopoxamine) is a local anaesthetic agent |
|
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | Method used to generate random sequence not described |
Allocation concealment (selection bias) | Unclear risk | Method not described |
Blinding (performance bias and detection bias) All outcomes | Unclear risk | Method not described |
Incomplete outcome data (attrition bias) All outcomes | Low risk | All participants completed study |
Size | High risk | < 50 participants per treatment arm |